Annual Long Term Liabilities:
$3.39M-$1.38M(-28.98%)Summary
- As of today, CPRX annual total long term liabilities is $3.39 million, with the most recent change of -$1.38 million (-28.98%) on December 31, 2024.
- During the last 3 years, CPRX annual long term liabilities has fallen by -$503.00 thousand (-12.92%).
- CPRX annual long term liabilities is now -77.99% below its all-time high of $15.40 million, reached on December 31, 2022.
Performance
CPRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$2.88M-$59.00K(-2.01%)Summary
- As of today, CPRX quarterly total long term liabilities is $2.88 million, with the most recent change of -$59.00 thousand (-2.01%) on June 30, 2025.
- Over the past year, CPRX quarterly long term liabilities has dropped by -$2.51 million (-46.52%).
- CPRX quarterly long term liabilities is now -84.34% below its all-time high of $18.39 million, reached on September 30, 2022.
Performance
CPRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CPRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -29.0% | -46.5% |
| 3Y3 Years | -12.9% | -22.7% |
| 5Y5 Years | +423.7% | +100.0% |
CPRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -78.0% | at low | -84.3% | at low |
| 5Y | 5-Year | -78.0% | >+9999.0% | -84.3% | >+9999.0% |
| All-Time | All-Time | -78.0% | >+9999.0% | -84.3% | >+9999.0% |
CPRX Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.88M(-2.0%) |
| Mar 2025 | - | $2.94M(-13.3%) |
| Dec 2024 | $3.39M(-29.0%) | $3.39M(-40.2%) |
| Sep 2024 | - | $5.67M(+5.3%) |
| Jun 2024 | - | $5.39M(-5.5%) |
| Mar 2024 | - | $5.70M(+19.3%) |
| Dec 2023 | $4.78M(-69.0%) | $4.78M(-30.4%) |
| Sep 2023 | - | $6.86M(-57.4%) |
| Jun 2023 | - | $16.10M(-4.5%) |
| Mar 2023 | - | $16.86M(+9.4%) |
| Dec 2022 | $15.40M(+295.6%) | $15.40M(-16.2%) |
| Sep 2022 | - | $18.39M(+393.2%) |
| Jun 2022 | - | $3.73M(-2.2%) |
| Mar 2022 | - | $3.81M(-2.1%) |
| Dec 2021 | $3.89M(>+9900.0%) | $3.89M(-2.0%) |
| Sep 2021 | - | $3.97M(-1.9%) |
| Jun 2021 | - | $4.05M(-1.9%) |
| Mar 2021 | - | $4.13M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(-100.0%) |
| Mar 2020 | - | $568.40K(-12.2%) |
| Dec 2019 | $647.50K(+318.3%) | $647.60K(-10.8%) |
| Sep 2019 | - | $725.70K(-9.4%) |
| Jun 2019 | - | $801.30K(-8.4%) |
| Mar 2019 | - | $875.10K(+465.3%) |
| Dec 2018 | $154.80K(-1.7%) | $154.80K(-6.1%) |
| Sep 2018 | - | $164.80K(+14.9%) |
| Jun 2018 | - | $143.40K(-4.7%) |
| Mar 2018 | - | $150.40K(-4.4%) |
| Dec 2017 | $157.50K(-48.1%) | $157.40K(-4.3%) |
| Sep 2017 | - | $164.50K(-3.5%) |
| Jun 2017 | - | $170.50K(-75.5%) |
| Mar 2017 | - | $695.50K(+129.2%) |
| Dec 2016 | $303.40K(-74.4%) | $303.40K(-26.8%) |
| Sep 2016 | - | $414.30K(+33.6%) |
| Jun 2016 | - | $310.20K(-33.4%) |
| Mar 2016 | - | $465.50K(-60.7%) |
| Dec 2015 | $1.18M | $1.18M(-22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $1.53M(-49.0%) |
| Jun 2015 | - | $2.99M(-16.4%) |
| Mar 2015 | - | $3.58M(+27.3%) |
| Dec 2014 | $2.81M(+52.9%) | $2.81M(-14.4%) |
| Sep 2014 | - | $3.28M(+38.1%) |
| Jun 2014 | - | $2.38M(+10.3%) |
| Mar 2014 | - | $2.15M(+17.2%) |
| Dec 2013 | $1.84M(+253.3%) | $1.84M(-48.4%) |
| Sep 2013 | - | $3.56M(+235.3%) |
| Jun 2013 | - | $1.06M(+88.1%) |
| Mar 2013 | - | $565.20K(+8.6%) |
| Dec 2012 | $520.50K(-68.5%) | $520.40K(-73.4%) |
| Sep 2012 | - | $1.96M(+217.6%) |
| Jun 2012 | - | $616.20K(-55.8%) |
| Mar 2012 | - | $1.39M(-15.8%) |
| Dec 2011 | $1.65M(>+9900.0%) | $1.65M(>+9900.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $10.70K(-27.2%) |
| Dec 2010 | $14.70K(-73.0%) | $14.70K(-21.8%) |
| Sep 2010 | - | $18.80K(-60.3%) |
| Jun 2010 | - | $47.40K(+1.3%) |
| Mar 2010 | - | $46.80K(-14.0%) |
| Dec 2009 | $54.40K(+27.7%) | $54.40K(+9.7%) |
| Sep 2009 | - | $49.60K(+36.3%) |
| Jun 2009 | - | $36.40K(-7.8%) |
| Mar 2009 | - | $39.50K(-7.3%) |
| Dec 2008 | $42.60K(-21.0%) | $42.60K(-6.8%) |
| Sep 2008 | - | $45.70K(-6.2%) |
| Jun 2008 | - | $48.70K(-4.7%) |
| Mar 2008 | - | $51.10K(-5.2%) |
| Dec 2007 | $53.90K(>+9900.0%) | $53.90K(>+9900.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2004 | $0.00 | $0.00 |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all-time high annual long term liabilities for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of CPRX is $3.39M
What is the all-time high annual long term liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual total long term liabilities is $15.40M
What is Catalyst Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, CPRX annual total long term liabilities has changed by -$1.38M (-28.98%)
What is Catalyst Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of CPRX is $2.88M
What is the all-time high quarterly long term liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $18.39M
What is Catalyst Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, CPRX quarterly total long term liabilities has changed by -$2.51M (-46.52%)